The portal uses cookies to provide service functions such as “Bookmark” and to improve website usage. Information and opt-out options can be found in the cookie settings in the privacy policy.

Search

1-991.0:

Other diagnostic measures: Molecular monitoring of residual tumor (MRD): Molecular genetic identification and preparation of patient-specific markers to identify residual tumor (minimal residual disease [MRD])

A test was carried to find out whether cancer cells were still in your body following treatment.

The tissue in the body is made up of cells. With cancer, the cells multiply uncontrollably, which leads to a malignant neoplasm (abnormal growth of tissue) developing. The cancer cells can destroy the healthy tissue and spread throughout the body. With cancer treatment, the aim is to destroy as many cancer cells as possible. However, individual cancer cells can survive in the body after treatment.

The investigation involves taking a blood sample or a sample from bone marrow. The bone marrow is inside the bone. The blood cells are formed in the bone marrow, for instance. The bone marrow also contains fat. The sample is then examined in a laboratory. First, we look for various characteristics that are typical for cancer cells.

Additional indicator

If necessary, additional letters are appended to OPS codes to indicate which side of the body is affected.

  • L: Left
  • R: Right
  • B: Both sides

Further information

Note

Your doctor will assist you with any health-related questions and explain the OPS code to you in a direct consultation if necessary.

Source

Provided by the non-profit organization “Was hab’ ich?” gemeinnützige GmbH on behalf of the Federal Ministry of Health (BMG).